# Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD

> **NCT07475052** · — · ENROLLING_BY_INVITATION · sponsor: **Xijing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Inflammatory Bowel Disease
- Heart Rate Variability
- Biologics
- Prediction
- Sleep Quality

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07475052
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-12-25
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475052, "Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07475052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*